‘Reassuring’ findings on buprenorphine in pregnancy


New findings on exposure to buprenorphine compared with methadone in pregnancy “help reinforce practices that we are already seeing,” says leading addiction pharmacist Researchers who studied more than 18,000 pregnancies exposed to buprenorphine or methadone have found there was no increased risk of long-term adverse neurodevelopmental outcomes among children with prenatal exposure to buprenorphine. The

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Consumers increasingly turning to pharmacy for flu vax
This is the most recent story.